Structural Aspects of the p53 Protein in Relation to Gene Evolution: A Second Look
The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Abstract
Several years ago, a comparison of the amino acid sequences of p53 proteins from a variety of species enabled us to reveal structural features of this protein, giving clues to its function. Since then, numerous studies on the biochemical, immunological and biological functions of p53 as well as on its structure (including crystallography data) have provided considerable insight into the multifunctional aspects of p53. The purpose of this review is to present the most recent data concerning the various structural features of the p53 protein with special emphasis on its flexibility, which plays a key role in regulation of its biological activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · cited 2×
“…a 21 kDa protein that specifically inhibits the kinase activity of the cdk2-cyclin complex required for the G1 to S transition of the cell-cycle (El-Deiry et al., 1993); the IGF-BP3 gene, which is also a negative regulator of cell proliferation (Buckbinder et al., 1995); the GADD45 gene, which…”
BackgroundParticipation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 4,296
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063 · cited 1×
“…that binds to PCNA (Smith et al., 1994) but with a controversial role in DNA repair (Kazantsev & Sancar, 1995; Kearsey et al., 1995); the Bax gene (Miyashita & Reed, 1995), whose product is involved in the regulation of 0022–2836/96/300623–15 $18.00/0 7 apoptosis ; and the mdm2 gene , which…”
BackgroundInfluentialMutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,961
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 4×
“This hypothesis has been confirmed by crystallographic data (Cho et al., 1994).”
BackgroundInfluentialDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,451
Finlay, C. A., Hinds, P. W., Tan, T. H., Eliyahu, D., Oren, M., & Levine, A. J. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.531 · Cited by 1,144
The structure and function of proline-rich regions in proteins
Williamson, M. P. (1994) · Biochemical Journal · doi:10.1042/bj2970249 · Cited by 1,005
Cited by
Items 101–200 of 208
p53: its alteration and gallbladder cancer
Rai, R., Tewari, M., Mohan Kumar, H., Singh, A. K., & Shukla, H. S. (2010) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328341e371 · Cited by 26
Generation of Anti-p53 Fab Fragments from Individuals with Colorectal Cancer Using Phage Display
Coomber, D., Hawkins, N. J., Clark, M. A., & Ward, R. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2276 · Cited by 26
cDNA cloning and expression analysis of flounder p53 tumour suppressor gene
Cachot, J., Galgani, F., & Vincent-Hubert, F. (1998) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s0305-0491(98)10133-5 · Cited by 25
Laverdiere, M., Beaudoin, J., & Lavigueur, A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.6.1489 · Cited by 28
In the Quest for Stable Rescuing Mutants of p53: Computational Mutagenesis of Flexible Loop L1
Pan, Y., Ma, B., Venkataraghavan, R. B., Levine, A. J., & Nussinov, R. (2005) · Biochemistry · doi:10.1021/bi047845y · Cited by 27
Mechanism of DNA-binding loss upon single-point mutation in p53
Wright, J. D., & Lim, C. (2007) · Journal of Biosciences · doi:10.1007/s12038-007-0083-3 · Cited by 23
On the Interaction Between p53 and MDM2: Transfer NOE Study of a p53-Derived Peptide Ligated to MDM2
Blommers, M. J. J., Fendrich, G., García-Echeverría, C., & Chêne, P. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9633171 · Cited by 24
TP53 in Myelodysplastic Syndromes
Jiang, Y., Gao, S., Soubise, B., Douet‐Guilbert, N., Liu, Z., & Troadec, M. (2021) · Cancers · doi:10.3390/cancers13215392 · Cited by 25
Mayr, B., Reifinger, M., & Loupal, G. (1998) · The Veterinary Journal · doi:10.1016/s1090-0233(98)80044-0 · Cited by 22
Shimokado, K., Watanabe, H., Sumii, M., Miyagawa, K., Kamiya, K., Dohi, K., & Niwa, O. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00558.x · Cited by 22
Comparison of the Human and Worm p53 Structures Suggests a Way for Enhancing Stability
Pan, Y., Ma, B., Levine, A. J., & Nussinov, R. (2006) · Biochemistry · doi:10.1021/bi052242n · Cited by 24
Nucleotide variation in the p53 tumor-suppressor gene of voles from Chernobyl, Ukraine
DeWoody, J. A. (1999) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(98)00171-5 · Cited by 21
Solution structure and binding specificity of the p63 DNA binding domain
Enthart, A., Klein, C., Dehner, A., Coles, M., Gemmecker, G., Kessler, H., & Hagn, F. (2016) · Scientific Reports · doi:10.1038/srep26707 · Cited by 20
D’Erchia, A. M., Pesole, G., Tullo, A., Saccone, C., & Sbisà, E. (1999) · Genomics · doi:10.1006/geno.1999.5794 · Cited by 21
Monti, P., Iannone, R., Campomenosi, P., Ciribilli, Y., Varadarajan, S., Shah, D., Menichini, P., Gold, B. I., & Fronza, G. (2004) · Biochemistry · doi:10.1021/bi035968x · Cited by 21
High affinity MAR-DNA binding is a common property of murine and human mutant p53
Will, K., Warnecke, G., Albrechtsen, N., Boulikas, T., & Deppert, W. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19980601)69:3<260::aid-jcb4>3.0.co;2-p · Cited by 21
Stability of the core domain of p53: insights from computer simulations
Madhumalar, A., Smith, D. J., & Verma, C. S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-s1-s17 · Cited by 23
Lee, S. Y., Jeon, H., Hwangbo, Y., Jeong, J. Y., Park, J. Y., Lee, E. J., Jin, G., Shin, K. M., Yoo, S. S., Lee, J., et al. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22077 · Cited by 20
Studies on modulation of the activity of tumor suppressor protein p53
Kadaja, L. (2004) · DSpace repository (University of Tartu) · Cited by 247
Cloning and comparative sequence analysis of TP53 in Xiphophorus fish hybrid melanoma models
Kazianis, S., Gan, L., Coletta, L. D., Santi, B., Morizot, D. C., & Nairn, R. S. (1998) · Gene · doi:10.1016/s0378-1119(98)00144-9 · Cited by 18
Chêne, P., & Bechter, E. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2738 · Cited by 17
Cheng, Z., Zhu, S., Wang, L., Liu, F., Tian, H., Pengsakul, T., & Wang, Y. (2015) · International Journal for Parasitology · doi:10.1016/j.ijpara.2015.02.010 · Cited by 18
Bjørling-Poulsen, M., Siehler, S. Y., Wiesmüller, L., Meek, D. W., Niefind, K., & Issinger, O. (2005) · Oncogene · doi:10.1038/sj.onc.1208762 · Cited by 16
Song, B., Wang, J., Ren, Y., Su, Y.-N., Geng, X., Yang, F., Wang, H., & Zhang, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114773 · Cited by 16
RetractedStavridi, E. S., Caruso, L. C., Chehab, N. H., & Halazonetis, T. D. (1999) · Protein Science · doi:10.1110/ps.8.9.1773 · Cited by 15
Fernandes, A. D., & Atchley, W. R. (2008) · Journal of Molecular Evolution · doi:10.1007/s00239-008-9124-2 · Cited by 16
Regulation of the cell cycle by p53 after DNA damage in an amphibian cell line
Bensaad, K., Rouillard, D., & Soussi, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204492 · Cited by 14
Self-citationPortefaix, J.-M., Thébault, S., Bourgain‐Guglielmetti, F., Rio, M. D., Granier, C., Mani, J. C., Navarro‐Teulon, I., Nicolas, M., Soussi, T., & Pau, B. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00246-5 · Cited by 14
Self-citationDias, D. P., & Milligan, R. A. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2597 · Cited by 14
p53: The Challenge of Linking Basic Science and Patient Management
Hall, P. A. (1998) · The Oncologist · doi:10.1634/theoncologist.3-4-218 · Cited by 13
Two different forms of p53 localized differently within cells of urogenital tumours
Benninghoff, J., Kartarius, S., Teleb, Z., Selter, H., Unteregger, G., Zwergel, T., Wullich, B., & Montenarh, M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00187-1 · Cited by 13
Cachot, J., Chérel, Y., Galgani, F., & Vincent-Hubert, F. (2000) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(99)00205-3 · Cited by 12
p53 – ein natürlicher Krebskiller: Einsichten in die Struktur und Therapiekonzepte
Römer, L., Klein, C., Dehner, A., Kessler, H., & Büchner, J. (2006) · Angewandte Chemie · doi:10.1002/ange.200600611 · Cited by 16
Overexpression of p73 causes apoptosis in vascular smooth muscle cells
Davis, B. B., Dong, Y., & Weiss, R. H. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00211.2002 · Cited by 12
The Challenge of p53: Linking Biochemistry, Biology, and Patient Management
Bray, S. E., Schorl, C., & Hall, P. A. (1998) · Stem Cells · doi:10.1002/stem.160248 · Cited by 15
Defining relative mutational difficulty to understand cancer formation
Shan, L., Yu, J., He, Z., Chen, S., Liu, M., Ding, H., Xu, L., Zhao, J., Yang, A. E., & Jiang, H. (2020) · Cell Discovery · doi:10.1038/s41421-020-0177-8 · Cited by 10
Purification of Recombinant p53 from Sf9 Insect Cells
Sun, X. Z., Nguyen, J., & Momand, J. A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-408-5:17 · Cited by 9
He, Z., Deng, F., Ma, Z., Zhang, Q., He, J., Ye, L., Chen, H., Yang, D., He, L., Luo, J., et al. (2021) · Aquaculture Reports · doi:10.1016/j.aqrep.2021.100675 · Cited by 11
Production of a polyclonal antibody raised against recombinant flounder p53 protein
Cachot, J., Galgani, F., & Vincent-Hubert, F. (1998) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/s0742-8413(98)00039-5 · Cited by 9
p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland
Niklińska, W., Burzykowski, T., Chyczewski, L., Rusin, M., Furman, M., Laudanski, J., Chyczewska, E., Sulik, M., & Nikliński, J. (2000) · European Journal of Cancer Prevention · doi:10.1097/00008469-200004000-00003 · Cited by 9
Novel Canine Tumour Suppressor Gene p53 Mutations in Cases of Skin and Mammary Neoplasms
Mayr, B., Reifinger, M., & Alton, K. (1999) · Veterinary Research Communications · doi:10.1023/a:1006314903272 · Cited by 9
Jardine, L., Milne, D., Dumaz, N., & Meek, D. W. (1999) · Oncogene · doi:10.1038/sj.onc.1203137 · Cited by 9
Interactivité entre p73 et p53 dans les cancers : un modèle, le neuroblastome
Douc‐Rasy, S., Goldschneider, D., Million, K., & Bénard, J. (2004) · médecine/sciences · doi:10.1051/medsci/2004203317 · Cited by 8
An intronic variant in the TP53 gene in a Brazilian woman with breast cancer
Lacerda, L. L., Serrano, S. V., Mathes, A. C. S., REY, J. A., Bello, M. J., & Casartelli, C. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.11.014 · Cited by 8
Lu-Hesselmann, J., Abend, M., & Beuningen, D. V. (2004) · Radiation Research · doi:10.1667/rr3092 · Cited by 7
Molecular characterization of the first non-mammalian p73 cDNA
Bhaskaran, A., May, D., Rand‐Weaver, M., & Tyler, C. R. (2000) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s0305-0491(00)00174-7 · Cited by 6
Gorlov, I. P., Gorlova, O. Y., & Amos, C. I. (2005) · Human Mutation · doi:10.1002/humu.20242 · Cited by 7
Mutation of p53 Tumor Suppressor Gene in Hepatocellular Carcinoma
Tullo, A., & Sbisà, E. (2003) · Humana Press eBooks · doi:10.1385/1-59259-079-9:113 · Cited by 6
Fijal, B. A., Idury, R. M., & Witte, J. S. (2002) · Statistics in Medicine · doi:10.1002/sim.1145 · Cited by 5
Mihailović, M., Dinić, S., Uskoković, A. S., PETROVIC, M., Grigorov, I., Poznanović, G., Ivanović‐Matić, S., & Bogojević, D. (2005) · Cell Biology International · doi:10.1016/j.cellbi.2005.07.003 · Cited by 6
Transcriptional properties of feline p53 and its tumour-associated mutants: a yeast-based approach
Cardellino, U., Ciribilli, Y., Andreotti, V., Modesto, P., Menichini, P., Fronza, G., Pellegrino, C., & Inga, A. (2007) · Mutagenesis · doi:10.1093/mutage/gem038 · Cited by 5
Tumor-infiltrating plasma cell profiling after PD-1 blockade reveals tumor-specific antibodies
Meyerhoff, R. R., Chen, A., O'Brien, J., Anadon, C. M., Lopez-Bailon, L. U., Carrión-Estrada, D. A., Poysungnoen, K., Lindenberger, J. J., Kemeny, G., Lyniv, L., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.07.001 · Cited by 4
Influence of the N-terminal region on the oligomerisation between human and Xenopus laevis p53
Chêne, P. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2734 · Cited by 4
Burr, P., Argyle, D. J., Reid, S., & Nasir, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202870 · Cited by 4
New mutations in the human p53 gene — a regulator of the cell cycle and carcinogenesis
Кашкин, К. Н., Khlgatian, S. V., Гурова, О. В., Kuprash, D. V., & Недоспасов, С. А. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907030054 · Cited by 4
Almazov, V. P., Morgunkova, A. A., Калинин, В. Н., Kopnin, B. P., Prasolov, V. S., & Chumakov, P. M. (2002) · Molecular Biology · doi:10.1023/a:1019856528001 · Cited by 5
Brzuzan, P., Woźny, M., Góra, M., Łuczyński, M. K., & Jabłońska, A. (2011) · Jagiellonian University Repository (Jagiellonian University) · Cited by 3
Ventura, A., do Nascimento, A. A., dos Santos, M. A. J., Vieira-Lopes, D. A., Sales, A., & Pinheiro, N. L. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1720-9 · Cited by 2
Attaleb, M., Berrada, N., Amzazi, S., Hassani, R. A. E., Benbacer, L., Abbar, M., Albouzidi, A., Khyatti, M., Elmzibri, M., & Ameur, A. (2013) · Clinical Cancer Investigation Journal · doi:10.4103/2278-0513.121521 · Cited by 2
A New Set of Monoclonal Antibodies Directed to Proline-Rich and Central Regions of p53
Voeltzel, T., Morel, A., Rostan, M.-C., Ji, J., Chiodino, C., Ponchel, F., Vigouroux, J., de Fromentel, C. C., Soussi, T., & Öztürk, M. (2004) · Hybridoma and Hybridomics · doi:10.1089/hyb.2004.23.287 · Cited by 3
Self-citationSelter, H., Schmidt, G., Villena-Heinsen, C. E., & Montenarh, M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(98)00356-5 · Cited by 2
(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1098-1004(1998)12:1 · Cited by 1
Jiang, Y., Wei, Y., Yang, D., Yao, J., Hu, Q., & Li, X. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48050447 · Cited by 1
Cyclopenta[c]phenanthrenes – Chemistry and biological activity
Brzuzan, P., Góra, M., Łuczyński, M. K., & Woźny, M. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.04.009 · Cited by 1
Tsai, W., & Barton, M. C. (2009) · Springer eBooks · doi:10.1007/978-3-642-00150-5_23 · Cited by 1
The p53 Tumor Suppressor Gene in Lung Cancer: From Molecular to Serological Diagnosis
Soussi, T., Trédaniel, J., Lubin, R., Zalcman, G., & Hirsh, A. (1998) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8924-7_19 · Cited by 1
Self-citationBarbisán, G. (2015) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/44757 · Cited by 2
Participation of tumor suppressor P53 in the expression of acute-phase protein genes
Mihailović, M., Poznanović, G., Dinić, S., Uskoković, A. S., Grdović, N., Vidaković, M., Јovanović, J. A., Grigorov, I., Ivanović‐Matić, S., Martinović, V., et al. (2007) · Archives of Biological Sciences · doi:10.2298/abs070333pm · Cited by 1
Junk, D. J. (2008) · UA Campus Repository (The University of Arizona) · Cited by 1
TP53 in Carcinogenesis and Cancer Prevention
Gormally, E., & Hainaut, P. L. (2003) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-08602-5_5
de Carvalho, R. M. (2011) · Americanae (AECID Library)
Structural and functional interrogation of Anterior Gradient-2
Gray, T. A. (2013) · ERA
Función del gen Snai3 (Smuc) en la transición epitelio mesenquimal y en cáncer
Gutsche, K. (2009) · Gredos (University of Salamanca) · doi:10.14201/gredos.76287
Meek, D. W., Campbell, L. C., Hall, S. R., Jardine, L., Knippschild, U., McKendrick, L., & Milne, D. (1998) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8950-6_8
CD 43 mõju uurimine rakkude kasvule
Jääger, K. (2007) · DSpace repository (University of Tartu)
TARGETING THE MDM2-P53 AXIS FOR THE TREATMENT OF DEDIFFERENTIATED LIPOSARCOMA
Bill, K. (2014) · Digital Commons-TMC (Texas Medical Center)
Mechanism of benzo(a)pyrene-induced accumulation of p53 tumour suppressor protein in mouse
Serpi, R. (2003) · Cited by 2
IN VIVO SIGNIFICANCE OF THE MDM4 AND P73 INTERACTION DURING DEVELOPMENT AND TUMORIGENESIS
Tashakori, M. (2015) · Digital Commons-TMC (Texas Medical Center)
Molekulare Grundlagen des Prostatakarzinoms
Elsässer‐Beile, U., Schultze-Seemann, W., & Wetterauer, U. (2002) · Springer eBooks · doi:10.1007/978-3-642-56297-6_11 · Cited by 3
Apoptosis and Cell Cycle Deregulation in Prostate Cancer
Bruckheimer, E. M., & Kyprianou, N. (2003) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860945601_0018
Protein Folding: From Normal Cellular Function to Pathophysiology
Rasool, M., Malik, A., Manan, A., Sultana, M., Qazi, M. H., & Pushparaj, P. N. (2015) · Springer eBooks · doi:10.1007/978-81-322-2467-9_5
Characterization of p53 in rainbow trout cell lines
Liu, M. (2010) · UWSpace (University of Waterloo)
Caracterización de nuevos perfiles moleculares en carcinoma de endometrio esporádico
Cieza-Borrella, C. (2013) · Gredos (University of Salamanca) · doi:10.14201/gredos.124099
Susceptibility genes in hereditary breast cancer
Vahteristo, P. (2003) · Helda - University of Helsinki Institutional Repository
Molecular genetic alterations in ovarian cancer
Reles, A. (2001) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/13801
Investigation of PIN1 as a Genetic Modifier in Li-Fraumeni Syndrome
Villani, A. (2015) · TSpace (University of Toronto)
Characterisation of the role of ING5
Basavarajaiah, P., & Lüscher, B. (2005) · RWTH Publications (RWTH Aachen)
Husaini, R. (2014) · Bradford Scholars (University of Bradford)
Construction of the pEGFP-N1-p53/MAR Vector and Its Effect on HEP3B Cell Morphology
Peng, S. L., Lei, X. Q., Xu, T. S., Wang, P. L., Song, Z., Li, Z. H., & Han, X. M. (2018) · Sains Malaysiana · doi:10.17576/jsm-2018-4709-19
Patched Domain-containing 4 (PTCH53) Identified in Li-Fraumeni Syndrome Patient-derived Cells
Pan, A. (2018) · TSpace (University of Toronto)
Knudsen, T. B., & Wubah, J. A. (1998) · Elsevier eBooks · doi:10.1016/b978-012648860-9.50014-5
Soto, J., Moody, C., Alhoshani, A., Sánchez-Bonilla, M., Martinon, D., & Cocco, M. J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.26.433080
p53 Protein, biological and clinical aspects
Soussi, T. (2001) · Springer eBooks · doi:10.1007/3-540-30683-8_1256
Self-citationDuncan, A. D., Tsai, W., & Barton, M. C. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch26
Facci, P. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-3142-8.00008-x
Function of the p53 Gene Family: A Holistic Perspective
Campbell, S. J., O'Neill, M. A., & Hall, P. A. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-720-8_4 · Cited by 1
Novel concepts in MDM2 protein regulation
Worrall, E. G. (2009) · ERA · Cited by 1
Metadata
- Authors
- Soussi, T., & May, P.
- Affiliations
- Inserm (FR)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Corresponding author
- Soussi, Thierry
- ORCID
- Soussi, Thierry
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 1996-08
- Volume
- 260
- Issue
- 5
- Pages
- 623-637
- ISSN
- 0022-2836 (ISSN-L)
- OpenAlex
- W2012183441
- Cited by
- 208
- References
- 141
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 6 · 2020: 1 · 2018: 4 · 2016: 3 · 2015: 6 · 2014: 5 · 2013: 7 · 2012: 1
- FWCI
- 13.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ligue Contre le Cancer
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, protein structure, gene evolution, protein flexibility, protein sequence comparison, crystallography, protein function, tumor suppressor
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cricetinae, Molecular Sequence Data, Phylogeny, Protein Conformation, Structure-Activity Relationship, Genes, p53, Tumor Suppressor Protein p53, Conserved Sequence, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Evolution, Molecular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.